Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893581 · ClinicalTrials.gov registry record · NA
Multimodal Neuroimaging of Treatment Effects in Adolescent Mania
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT00893581 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 169 participants.
The verdict
NCT00893581, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
Specific Aim 1: To determine the effects of treatment with quetiapine or lithium on brain activation in adolescents. The investigators will use functional magnetic resonance imaging (fMRI) to examine brain activation during an attentional task. Specific Aim 2: To determine the effects of treatment with quetiapine or lithium on neurometabolite measures, early in their illness course. The investigators will use 1H-MRS to identify myo-inositol (mI), N-acetyl aspartate (NAA), and glutamate (Glu) levels in prefrontal ALN regions. Specific Aim 3: To determine the relationships among the changes in brain activation and neurometabolite measures, as well as symptomatic improvement in manic adolescents.
Interventions
- OTHER Healthy Controls
- DRUG Quetiapine & Placebo
- DRUG Lithium and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00893581
The ClinicalTrials.gov registry entry for NCT00893581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Healthy Controls is the first listed.
NCT00893581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00893581 about?
NCT00893581 is a clinical study titled "Multimodal Neuroimaging of Treatment Effects in Adolescent Mania". Specific Aim 1: To determine the effects of treatment with quetiapine or lithium on brain activation in adolescents. The investigators will use functional magnetic resonance imaging (fMRI) to examine brain activation during an attentional task. Specific Aim 2: To determine the effects of treatment ...
What is the current status of trial NCT00893581?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2009-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT00893581?
The interventions under investigation include: Healthy Controls (OTHER), Quetiapine & Placebo (DRUG), Lithium and Placebo (DRUG).
Who is sponsoring clinical trial NCT00893581?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.